Breast cancer cells with HRs expressing estrogen (ER), progesterone (PR), or both are referred to as ER-positive (ER +), PR-positive (PR +), or ER/PR positive (ER + /PR +) breast cancers, respectively. This evidence concerns the gene PGR and breast carcinoma.